The medical landscape is witnessing a shift with the introduction of GLP-1 transdermal systems . These innovative formulations offer a possible alternative to providing glucagon-like peptide-1 drugs for https://laylawzqq012969.activablog.com/39964460/glp-1-patches-a-novel-way-to-treat-diabetes